Clinical Trial

Registry of Secondary Revascularization

Study acronym: REVASEC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study will evaluate patients with, at least, one previous procedure of coronary revascularization (surgical, percutaneous or both), that are referred for a new, clinically indicated, diagnostic coronary angiography, to describe their clinical characteristics, management, and prognosis, and will propose a prognosis-oriented classification.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2017-11-19; most recent amendment 2025-04-23.
Status change: Recruiting → Active, Not Recruiting 2020-01-20
Status change: Not Yet Recruiting → Recruiting 2017-11-22
Trial Details
NCT Number NCT03349385
Lead Sponsor Hospital San Carlos, Madrid
Collaborators: Laboratorios Farmacéuticos Rovi, S.A., S&H MEDICAL SCIENCE SERVICE, S.L.
Conditions Coronary Artery Disease Progression, Coronary Artery Disease of Significant Bypass Graft, Stent Stenosis, Stent Restenosis, Coronary Arteriosclerosis
Enrollment 869 participants
Start Date 2017-11-22
Primary Completion 2021-05-31 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-24